Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased hepatic insulin clearance after Roux-en-Y gastric bypass.
Bojsen-Møller KN, Dirksen C, Jørgensen NB, Jacobsen SH, Hansen DL, Worm D, Naver L, Kristiansen VB, Holst JJ, Madsbad S. Bojsen-Møller KN, et al. Among authors: worm d. J Clin Endocrinol Metab. 2013 Jun;98(6):E1066-71. doi: 10.1210/jc.2013-1286. Epub 2013 Apr 22. J Clin Endocrinol Metab. 2013. PMID: 23609835
Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Jørgensen NB, Dirksen C, Bojsen-Møller KN, Jacobsen SH, Worm D, Hansen DL, Kristiansen VB, Naver L, Madsbad S, Holst JJ. Jørgensen NB, et al. Among authors: worm d. Diabetes. 2013 Sep;62(9):3044-52. doi: 10.2337/db13-0022. Epub 2013 May 6. Diabetes. 2013. PMID: 23649520 Free PMC article.
Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Dirksen C, Bojsen-Møller KN, Jørgensen NB, Jacobsen SH, Kristiansen VB, Naver LS, Hansen DL, Worm D, Holst JJ, Madsbad S. Dirksen C, et al. Among authors: worm d. Diabetologia. 2013 Dec;56(12):2679-87. doi: 10.1007/s00125-013-3055-1. Epub 2013 Sep 19. Diabetologia. 2013. PMID: 24048673 Clinical Trial.
Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN, Dirksen C, Jørgensen NB, Jacobsen SH, Serup AK, Albers PH, Hansen DL, Worm D, Naver L, Kristiansen VB, Wojtaszewski JF, Kiens B, Holst JJ, Richter EA, Madsbad S. Bojsen-Møller KN, et al. Among authors: worm d. Diabetes. 2014 May;63(5):1725-37. doi: 10.2337/db13-1307. Epub 2013 Nov 15. Diabetes. 2014. PMID: 24241533 Clinical Trial.
Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report.
Dirksen C, Jacobsen SH, Bojsen-Møller KN, Jørgensen NB, Naver LS, Hvolris LE, Worm D, Madsbad S, Holst JJ, Hansen DL. Dirksen C, et al. Among authors: worm d. Obes Res Clin Pract. 2013 Jul-Aug;7(4):e269-74. doi: 10.1016/j.orcp.2012.01.002. Obes Res Clin Pract. 2013. PMID: 24306154
Carotid intima-media thickness is reduced 12 months after gastric bypass surgery in obese patients with type 2 diabetes or impaired glucose tolerance.
Lundby-Christensen L, Tarnow L, Hansen DL, Worm D, Naver LS, Hvolris LE, Wiinberg N, Vaag A, Almdal TP. Lundby-Christensen L, et al. Among authors: worm d. J Diabetes Complications. 2014 Jul-Aug;28(4):517-22. doi: 10.1016/j.jdiacomp.2014.03.005. Epub 2014 Mar 12. J Diabetes Complications. 2014. PMID: 24685364
55 results